Each company will be featured at Plastic Surgery The Meeting, Oct. 26-29 in Austin, Texas.
Five plastic surgery startups made it to the finals of MedTech Innovator (MTI)/ American Society of Plastic Surgeons (ASPS) accelerator track in the 2023 MedTech Innovator Accelerator program and competition.
The plastic surgery track startups selected to advance include:
- 4th Dimension EMR (San Diego, Calif.)
- Cellulora (Philadelphia)
- Fingy 3D (Morgantown, W.Va.)
- ImmersiveTouch (Chicago)
- Newrotex (Oxford, U.K.)
The join a field of 61 startups from around the world that will compete for a share of $800,000 in funding awards over the course of the four-month program.
“Plastic surgery thrives on innovation and attracts creative, entrepreneurial individuals who are constantly striving to improve outcomes and safety for patients,” says ASPS President Gregory Greco, DO, FACS, Red Bank, N.J, in a news release. “This program provides enormous value to ASPS members looking to bring their ideas to market – but it also advances the specialty and, most importantly, holds the potential to improve care worldwide.”
More than 70 companies entered the MTI/ASPS Plastic Surgery Accelerator competition this year, and 12 advanced to the live-pitch judging phase, where the top five were selected to represent the plastic surgery track.
ASPS participation in the MTI/ASPS Plastic Surgery Accelerator is made possible through the generous support of Motiva, the Society’s 2023 Innovation Sponsor.
Each of the five cohort participants will be featured at Plastic Surgery The Meeting, Oct. 26-29 in Austin, Texas, and receive mentoring from ASPS surgeons and associated entrepreneurs. They will also participate in MedTech Innovator’s corporate mentorship program, where they will be matched with senior industry leaders to receive ongoing in-depth, customized mentorship and support.
“We are proud of our stellar track record of identifying and perfecting the most innovative medtech startups in the world,” says Paul Grand, CEO and founder of MedTech Innovator. “The 2023 MedTech Innovator Cohort once again includes passionate medtech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical device, diagnostic and digital health innovations to improve patient care.”
This is the second year of the ASPS/MTI partnership, but since the launch of MedTech Innovator in 2013, more than 500 companies completed the program, resulting in more than 200 FDA approvals and clearances, and $6.8 billion in funding.
The 2023 accelerator program launches June 14-15 at the MedTech Innovator Summit in Mountain View, Calif. Leadership teams from each of the 61 startups will attend networking events and workshops with MedTech Innovator partners, alumni and industry leaders.
